Somatomedin-C/insulin-like growth factor-I and small cell lung cancer
Author Information
Author(s): V.M. Macauly, J.D. Teale, M.J. Everard, G.P. Joshi, I.E. Smith, J.L. Millar
Primary Institution: Institute of Cancer Research, Royal Marsden Hospital
Hypothesis
Is somatomedin-C/insulin-like growth factor-I a mitogen for human small cell lung cancer?
Conclusion
Somatomedin-C may function as an autocrine growth factor in small cell lung cancer.
Supporting Evidence
- Immunoreactive somatomedin-C was detectable in all small cell lung cancer samples.
- Biosynthetic somatomedin-C enhanced DNA synthesis in classic and variant small cell lung cancer lines.
- Most non-small cell lung cancer tissues expressed detectable somatomedin-C.
Takeaway
This study found that a substance called somatomedin-C helps small cell lung cancer cells grow, which could lead to new treatments.
Methodology
The study used radioimmunoassay to measure levels of somatomedin-C in lung cancer cell lines and tissues, and assessed its mitogenic effects using 3H-thymidine uptake.
Limitations
The study did not assess the effect of somatomedin-C in combination with other growth factors.
Participant Demographics
Included 18 patients with small cell lung cancer and 6 with non-small cell lung cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website